HAE Attack Symptoms When to Treat an Attack On-Demand Medications When to Call 911 On-demand or acute treatment for hereditary angioedema (HAE) attacks is crucial for getting your symptoms under ...

Scientists are aiming to grow 4,500 trees at a national park with the help of fertiliser made from urine collected from festivalgoers. The fertiliser was created by Bristol-based start-up NPK Recovery ...

Former South Korean prime minister Lee Hae-chan has died of illness after a period of medical treatment in Ho Chi Minh City, according to Vietnam's Ministry of Foreign Affairs. Foreign ministry ...

Lee Hae-in is one of South Korea’s most inspiring figure skaters right now. At just 20 years of age, she has secured her first Olympic ticket after finishing second at the national trials. Her ...

Living with hereditary angioedema (HAE) means navigating a rare condition that causes painful swelling in various parts of the body, often including the face, hands, feet, genitals, abdomen, and ...

Jang Hae Young, a member of the K-pop group F-IVE, has passed away at the age of 45 due to complications from cancer. He had been battling the disease for a prolonged period. His fellow group member, ...

The American medicines regulator has ended a barren stretch in hereditary angioedema with three approvals in 2025, according to an analysis from GlobalData. The surge brings the total number of ...

HAE-related symptoms can adversely impact the quality of life and education of pediatric patients. Among pediatric patients with hereditary angioedema (HAE), adolescent girls are disproportionally ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min KalVista's journey to FDA ...

Prophylaxis does not entirely eliminate the risk for angioedema, so first-line agents must be available during a surgical intervention, and the team must be prepared for urgent airway management. The ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it will present additional data from the pivotal Phase 3 OASIS and OASISplus studies, as well as ...